《Reviews In Cardiovascular Medicine》重点专注发布医学-心血管系统领域的新研究，旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。该杂志创刊至今，在医学-心血管系统领域，有较高影响力，对来稿文章质量要求较高，稿件投稿过审难度较大。欢迎广大同领域研究者投稿该杂志。
| CiteScore | SJR | SNIP | CiteScore排名 | |||
|---|---|---|---|---|---|---|
| 2.7 | 0.518 | 0.587 | 学科类别 | 分区 | 排名 | 百分位 |
|
大类：大类：Medicine
小类：小类：CardiologyandCardiovascularMedicine
|
Q3 | 216/387 | 44% | |||
| 按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | 123 / 220 | 44.3% |
| 按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | 134 / 220 | 39.32% |
文章名称
引用次数
Activation of beta(1)-adrenoceptors may not be involved in arrhythmogenesis in ischemic heart disease
17
Inhibition of the Sodium-Proton Antiporter (Exchanger) is a Plausible Mechanism of Potential Benefit and Harm for Drugs Designed to Block Sodium Glucose Co-transporter 2
12
Cardiorenal Outcomes in the CANVAS, DECLARE-TIMI and EMPA-REG OUTCOME Trials: A Systematic Review
9
Epidemiology of cardiovascular risk in chronic kidney disease patients: the real silent killer
7
Alteration of lipid metabolism in chronic kidney disease, the role of novel antihyperlipidemic agents, and future directions
7
Emerging role of non-coding RNAs and extracellular vesicles in cardioprotection by remote ischemic conditioning of the heart
6
Contribution of ApoCIII to Diabetic Dyslipidemia and Treatment With Volanesorsen
6
Can We Cure Atherosclerosis?
6
Advances in epigenetic regulation of vascular aging
6
Inhibition of miR-34a-5p protected myocardial ischemia reperfusion injury-induced apoptosis and reactive oxygen species accumulation through regulation of Notch Receptor 1 signaling
5
国家/地区
发文量
TUSA
57
TCHINA MAINLAND
31
TItaly
13
TCanada
7
TGERMANY (FED REP GER)
5
TRomania
5
TEngland
4
TSouth Korea
4
TGreece
3
TIndia
3
